NaNotics has a total of 79 patents globally, out of which 15 have been granted. Of these 79 patents, more than 84% patents are active. The United States of America, Japan and China is where NaNotics has filed the maximum number of patents, followed by Singapore, Hong Kong (S.A.R.) and
Happe Spine has a total of 15 patents globally, out of which 5 have been granted. Of these 15 patents, more than 80% patents are active. The United States of America is where Happe Spine has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States
EnLiSense has a total of 7 patents globally, out of which 2 have been granted. Of these 7 patents, more than 85% patents are active. The United States of America is where EnLiSense has filed all their patents. Parallelly, United States of America seems to be the main focused R&D
CytoVeris has a total of 31 patents globally, out of which 4 have been granted. Of these 31 patents, more than 74% patents are active. The United States of America is where CytoVeris has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to
Intabio Inc has a total of 29 patents globally, out of which 5 have been granted. Of these 29 patents, more than 65% patents are active. Korea (South) is where Intabio Inc has filed the maximum number of patents, followed by the United States of America and Canada. Parallelly, the
Synthekine has a total of 168 patents globally, out of which 4 have been granted. Of these 168 patents, more than 80% patents are active. Europe (EPO) is where Synthekine has filed the maximum number of patents, followed by Canada. Parallelly, the USA seems to be the main focused R&D
Envisagenics has a total of 18 patents globally, out of which no patent has been granted. Of these 18 patents, more than 83% patents are active. United States of America seems to be the main focused R&D centre and also is the origin country of Envisagenics. Envisagenics was founded in
Tvardi Therapeutics has a total of 51 patents globally, out of which 9 have been granted. Of these 51 patents, more than 96% patents are active. The United States of America is where Tvardi Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be
OrphoMed has a total of 81 patents globally, out of which 42 have been granted. Of these 81 patents, more than 72% patents are active. United States of America seems to be the main focused R&D centre and also is the origin country of OrphoMed. OrphoMed was founded in 2015.
Ensoma has a total of 20 patents globally. Of these 20 patents, more than 80% patents are active. United States of America seems to be the main focused R&D centre and also is the origin country of Ensoma. Ensoma was founded in 2019. Ensoma is a biotechnology company. The company
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.